Nova's mission is to support better preclinical and clinical research and development of new drugs and therapies for the best matching patients. With Nova's in-silico trials design and simulation platform, jinko, clinical trials are run through computer modeling with a disease model and a virtual population representative of any specific context or geographical location. Disease models are translated into mathematical representations of physiological knowledge. Existing trial data can be harmonized and extrapolated. Where no data from previous trials are available, trials can be simulated to generate synthetic data.
